4DMedical Ltd
ASX:4DX

Watchlist Manager
4DMedical Ltd Logo
4DMedical Ltd
ASX:4DX
Watchlist
Price: 0.445 AUD -2.2%
Market Cap: 183m AUD
Have any thoughts about
4DMedical Ltd?
Write Note

4DMedical Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

4DMedical Ltd
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
4DMedical Ltd
ASX:4DX
Total Equity
AU$70.9m
CAGR 3-Years
-5%
CAGR 5-Years
73%
CAGR 10-Years
N/A
Mach7 Technologies Ltd
ASX:M7T
Total Equity
AU$51.9m
CAGR 3-Years
-4%
CAGR 5-Years
38%
CAGR 10-Years
58%
CogState Ltd
ASX:CGS
Total Equity
$40.9m
CAGR 3-Years
23%
CAGR 5-Years
32%
CAGR 10-Years
13%
Pro Medicus Ltd
ASX:PME
Total Equity
AU$187.7m
CAGR 3-Years
32%
CAGR 5-Years
31%
CAGR 10-Years
25%
Medibio Ltd
ASX:MEB
Total Equity
AU$6.3m
CAGR 3-Years
-21%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Medadvisor Ltd
ASX:MDR
Total Equity
AU$51.6m
CAGR 3-Years
2%
CAGR 5-Years
N/A
CAGR 10-Years
67%
No Stocks Found

4DMedical Ltd
Glance View

Market Cap
182.6m AUD
Industry
Health Care

4DMedical Ltd. is a software technology company, which commercializes four-dimensional lung imaging platform called XV Technology. The company is headquartered in Melbourne, Victoria. The company went IPO on 2020-08-07. The firm is focused on development of a non-invasive respiratory imaging solution using four-dimensional imaging. The firm's XV Technology is a four-dimensional lung imaging technology that utilizes mathematical models and algorithms to convert X-ray scans into quantitative data for physicians to manage patients with respiratory diseases and diseases of the lung. The XV Technology is accessible through a cloud-based software as a service (SaaS) platform that integrates with existing hospital equipment. The XV Technology Lung Ventilation Analysis Software (XV LVAS Ventilation) provides a non-invasive way of understanding regional lung motion and airflow. The company enables physicians to detect areas of high and low ventilation from all parts of the lung, in all phases of the breath.

4DX Intrinsic Value
0.467 AUD
Undervaluation 5%
Intrinsic Value
Price

See Also

What is 4DMedical Ltd's Total Equity?
Total Equity
70.9m AUD

Based on the financial report for Jun 30, 2024, 4DMedical Ltd's Total Equity amounts to 70.9m AUD.

What is 4DMedical Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
73%

Over the last year, the Total Equity growth was -1%. The average annual Total Equity growth rates for 4DMedical Ltd have been -5% over the past three years , 73% over the past five years .

Back to Top